Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002399059 | SCV002714183 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-02-22 | criteria provided, single submitter | clinical testing | The c.1721_1722delTC pathogenic mutation, located in coding exon 15 of the MLH1 gene, results from a deletion of two nucleotides at nucleotide positions 1721 to 1722, causing a translational frameshift with a predicted alternate stop codon (p.L574Qfs*10). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |